Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages 1232-1238

  Suzuki, Toshiyuki ^a   Sadahiro, Sotaro ^a   Tanaka, Akira ^a   Okada, Kazutake ^a   Kamata, Hiroko ^a   Kamijo, Akemi ^a   Murayama, Chieko ^b   Akiba, Takeshi ^b   Kawada, Shuichi ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL CARCINOMA; LOCAL RECURRENCE; LOCALLY ADVANCED RECTAL CANCERS; METHODS AND MATERIALS; PATHOLOGIC COMPLETE RESPONSE; PREOPERATIVE CHEMORADIATION; RECTAL CANCER; TUMOR REGRESSION;

BIOPSY; CHEMORADIOTHERAPY; DISEASES; PATHOLOGY; REGRESSION ANALYSIS; SHRINKAGE; TUMORS;

CELL DEATH;

EOSIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HEMATOXYLIN; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P51; UFT;

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PREOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; TUMOR REGRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BIOPSY; CHEMORADIOTHERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG COMBINATIONS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; OXONIC ACID; RECTAL NEOPLASMS; RECTUM; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875277628     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.031     Document Type: Article

References (25)

1. K.C. Peeters, C.A. Marijnen, and I.D. Nagtegaal The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
4. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
5. L.F. de Campos-Lobato, L. Stocchi, and A. da Luz Moreira Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers Ann Surg Oncol 17 2010 1758 1766
6. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
7. M. Mohiuddin, M. Hayne, and W.F. Regine Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 2000 1075 1080
8. H.J. Chang, K.H. Jung, and D.Y. Kim Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma Hum Pathol 36 2005 364 371
9. C. Jakob, T. Liersch, and W. Meyer Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy World J Gastroenterol 14 2008 1060 1066
10. J.G. Kuremsky, J.E. Tepper, and H.L. McLeod Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 2009 673 688
11. C. Rodel, G.G. Grabenbauer, and T. Papadopoulos Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Radiat Oncol Biol Phys 52 2002 294 303
12. C.G. Willett, G. Warland, and M.P. Hagan Tumor proliferation in rectal cancer following preoperative irradiation J Clin Oncol 13 1995 1417 1424
13. T. Nakano, and K. Oka Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study Cancer 68 1991 517 523
14. D.F. Parsons An electron microscope study of radiation damage in the mouse oocyte J Cell Biol 14 1962 31 48
15. Japanese Society for Cancer of the Colon and Rectum Japanese Classification of Colorectal Carcinoma 1st ed. 1997 Kanehara Tokyo
16. S. Sadahiro, T. Suzuki, and A. Tanaka Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma Oncology 81 2011 306 311
17. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686
18. T. Suzuki, S. Sadahiro, and M. Fukasawa Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer Jpn J Clin Oncol 34 2004 740 746
19. S.G. Yeo, D.Y. Kim, and T.H. Kim Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 78 2010 164 171
20. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
21. C. Berger, A. de Muret, and P. Garaud Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications Int J Radiat Oncol Biol Phys 37 1997 619 627
22. H. Namba, T. Hara, and T. Tukazaki Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells Cancer Res 55 1995 2075 2080
23. S. Fan, W.S. el-Deiry, and I. Bae p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents Cancer Res 54 1994 5824 5830
24. W.S. el-Deiry, J.W. Harper, and P.M. O'Connor WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54 1994 1169 1174
25. I. Chau, G. Brown, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clin Oncol 24 2006 668 674